Skip to main content

Peer Review reports

From: Systemic immune-inflammation index predicts prognosis of sequential therapy with sorafenib and regorafenib in hepatocellular carcinoma

Original Submission
21 Jul 2020 Submitted Original manuscript
29 Aug 2020 Reviewed Reviewer Report
30 Sep 2020 Reviewed Reviewer Report - Joseph Abi Jaoude
3 Nov 2020 Author responded Author comments - Young Mi Hong
Resubmission - Version 2
3 Nov 2020 Submitted Manuscript version 2
26 Dec 2020 Reviewed Reviewer Report - Joseph Abi Jaoude
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
29 Mar 2021 Editorially accepted
18 May 2021 Article published 10.1186/s12885-021-08124-9

You can find further information about peer review here.

Back to article page